Patent ID: 9018250
Filing Date: 2015-04-28
Classification: A61K,A61P,Y10S

Abstract:
1. A pharmaceutical composition comprising 20-40 wt % of at least one active principle selected from (i) 2-n-butyl-3-[4-(3-di-n-butylaminopropoxy)benzoyl]-5-methylsulfonamidobenzofuran in the form of base and (ii) 2-n-butyl-3-[4-(3-di-n-butylaminopropoxy)benzoyl]-5-methylsulfonamidobenzofuran in the form of a pharmaceutically acceptable salt; and 50-60 wt % of at least one amphiphilic lipid excipient with HLB value between 2 and 20 selected from the semi-solid substituted glycerides, the liquid substituted glycerides, the semi-solid substituted polyoxylglycerides, the liquid substituted polyoxylglycerides and mixtures thereof; wherein the percentages are expressed by weight relative to the total weight of said composition.